Research output per year
Research output per year
Personal profile
Overview
Dr Morgan is a Clinical Senior Lecturer at The University of Manchester and an Honorary Consultant in Medical Oncology at The Christie NHS Foundation Trust.
He graduated from University College London and completed his general medical training in Oxford and London, before undertaking Specialty Training in Medical Oncology in Oxford and Manchester. During Specialty Training, he was awarded a CRUK Clinical Research Training Fellowship and completed his PhD in Cancer Biology at The University of Manchester, under the supervision of Professor Stephen Taylor and Professor Gordon Jayson. He continued his research in the Mitosis and Cancer Pharmacology group as an NIHR Academic Clinical Lecturer, after which he was appointed to his current role.
His research interests include hereditary ovarian cancer and developing new biomarkers to aid first-line therapy for ovarian cancer. He collaborates with expert scientists within The University and leading clinicians within the NHS. He is a Principal Investigator for several clinical trials in ovarian cancer at The Christie.
Qualifications
BSc (Hons 1), MB, BS, PhD, MRCP
My collaborations
Prof Stephen Taylor
Prof Gordon Jayson
Prof D Gareth Evans
Prof Richard Edmondson
Prof Pat Caswell
Prof Kevin Couper
Prof James O'Connor
Dr Andrew Clamp
Dr George Burghel
Dr Bethany Barnes
Dr Camilla Coulson-Gilmer
Dr Cong Zhou
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Doctor of Philosophy, The University of Manchester
Award Date: 14 Dec 2021
Bachelor of Medicine and Bachelor of Surgery, University College London (UCL)
Award Date: 15 Jul 2010
External positions
Honorary Consultant in Medical Oncology, The Christie NHS Foundation Trust
5 May 2025 → …
Fingerprint
Dive into the research topics where Robert Morgan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
An Advanced Clinical Practitioner And Specialist Clinical Pharmacist-Led Outpatient Service To Deliver Maintenance Poly (ADP-Ribose) Polymerase Inhibitors Therapies To Treat Women With Advanced-Stage Or Relapsed, Platinum-Sensitive High-Grade Epithelial Ovarian Cancer
Donaldson, C., Sterigou, P., Collins, J., Penn, S., Moohan, E., Morgan, R. D., Salih, Z., Mitchell, C., Clamp, A. R., Jayson, G. C. & Hasan, J., 17 Feb 2025, In: International Journal of Gynecological Cancer. 35, 2 S1, p. 51 1 p.Research output: Contribution to journal › Meeting Abstract › peer-review
-
Borderline ovarian tumours
Baker-Rand, H., Bolton, J., Morgan, R. & Edmondson, R., 11 Sept 2025, In: The Obstetrician & Gynaecologist. p. 1 11 p.Research output: Contribution to journal › Review article › peer-review
-
Breast cancer incidence in ovarian cancer survivors with BRCA mutations: A multicentre retrospective cohort study
Yongue, M. G., Counsell, N., Morgan, R. D., Tookman, L., Devlin, M. J., Mille, R., Modawi, M., Leytes, S., Hunt, A., Clamp, A. R., Evans, G., Jayson, G. C., Elyashiv, O., Levy, T., Lederman, J., Abu Remilah, A. & Nicum, S., 17 Aug 2025, In: BJOG. 132, S7, p. 101-101 1 p., SO-4.Research output: Contribution to journal › Meeting Abstract › peer-review
-
Homologous recombination deficiency in unselected cases of high-grade ovarian carcinoma
Morgan, R. D., Burghel, G. J., Shaw, J., Schlecht, H., Baishnab, D., Pilkington, T., Desai, S., Salih, Z., Mitchell, C., Hasan, J., Clamp, A. R., Jayson, G. C., Taylor, S. & Evans, D. G., 14 Aug 2025, (E-pub ahead of print) In: Journal of Medical Genetics.Research output: Contribution to journal › Article › peer-review
-
Low likelihood of tumour homologous recombination deficiency (HRD) in high-grade ovarian carcinomas (HGOCs) harbouring a germline BRIP1 or PALB2 pathogenic variant (PV)
Connors, K., Burghel, G. J., Ramsden, C., Salih, Z., Mitchell, C., Hasan, J., Clamp, A. R., Jayson, G. C., Evans, G., Taylor, S. & Morgan, R. D., Sept 2025, In: Annals of Oncology. 36, 2 p.Research output: Contribution to journal › Meeting Abstract › peer-review
Thesis
-
Novel therapeutic strategies to treat high-grade serous ovarian carcinoma by targeting modulators of PAR dynamics
Morgan, R. (Author), Springer, C. (Supervisor), Jayson, G. (Supervisor) & Taylor, S. (Supervisor), 14 Dec 2021Student thesis: Phd
File